Search Results - "Angiotensin-converting enzyme inhibitor"

Management of renin-angiotensin system inhibitors prior to major surgery: insights from the STOP-or-NOT trial.

Legrand, Matthieu, Gayat, Etienne

application/pdf

Comparison between the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and their combination on mortality in maintenance dialysis patients: a systematic review and meta-analysis

Elkoumi, Omar^{Aff1, Aff11, IDs1125502404322z_cor1}, Elkoumi, Ahmed^{Aff2, Aff11}, Elbairy, Mariam Khaled^{Aff1, Aff11}, Irfan, Hamza, Beddor, Ahmad^{Aff4, Aff11}, Mahmoud, Mostafa Adel T.^{Aff5, Aff11}, Habib, Omar K.^{Aff6, Aff11}, Hendi, Nada Ibrahim^{Aff7, Aff11}, Abdulgadir, Ayah, Alawlaqi, Bandar, Hamed, Sarah, Ghanem, Ahmed K.

Heart failure with preserved ejection fraction therapeutics: in search of the pillars

Rafei, Abdelghani El^{Aff1, Aff2, IDs1074102510524z_cor1}, Harrington, Josephine A.^{Aff1, Aff2}, Tavares, Caio A. M.^{Aff3, Aff4}, Guimarães, Patrícia O., Ambrosy, Andrew P.^{Aff5, Aff6}, Bonaca, Marc P.^{Aff1, Aff2}, Sauer, Andrew J., Vardeny, Orly, Canonico, Mario Enrico^{Aff1, Aff2}

Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR

Mei, Mei^{Aff1, Aff3}, Zeng, Jun^Aff2, Fang, Li, Xiang, Sha, Sun, Haili, Wen, Chaolin, Chai, Liyin, Chen, Xinqing, Li, Zhuhong, Li, Ning, Shen, Bingbing^{Aff2, Aff3, IDs11255024041569_cor1}

Real‐world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure

Ankeet S. Bhatt, Muthiah Vaduganathan, Barada P. Jena, Sylwia Suminska, Carlos Eid, Heike Schwende, Michele Senni

electronic resource

View item

Comparative safety and effectiveness of angiotensin converting enzyme inhibitors and thiazides and thiazide-like diuretics under strict monotherapy.

Anand, Tara, Bu, Fan, Schuemie, Martijn, Suchard, Marc, Hripcsak, George

application/pdf

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis

Zehui Yao, Dailei Qin, Jianzhong Cao, Chun Gao, Pu Xi, Shengping Li, Ran Wei

electronic resource

View item

Hyperkalemia Is an Underestimated Risk Factor in COPD

Mäenpää J, Anderson I, Owen CA, Emerath U, Hughes R, Sultana SR, Olsson M

electronic resource

View item; View item

Effect of Post-Acute Kidney Injury Use of Renin-Angiotensin Inhibitors on Long-term Mortality and Major Adverse Kidney Events: A 5-year Retrospective Observational Cohort Study

Byorn W.L. Tan, Bryce W.Q. Tan, K. Akalya, Wei-Zhen Hong, Yi Da, Sanmay Low, Wan-Ying Ng, Horng-Ruey Chua

electronic resource

View item; View item

Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials

Rindone, Joseph P.^{Aff1, IDs00228024036866_cor1}, Mellen, Chadwick K.

A GWAS of angiotensin-converting enzyme inhibitor-induced angioedema in a South African population

Jacquiline W. Mugo, PhD, Cascia Day, Cert Allergy (Phys), Ananyo Choudhury, PhD, Maria Deetlefs, Dip Allergy (SA), Robert Freercks, MPhil, Sian Geraty, MMed, Angelica Panieri, MBChB, Christian Cotchobos, MBChB, Melissa Ribeiro, MBChB, Adelein Engelbrecht, MMed, Lisa K. Micklesfield, PhD, Michèle Ramsay, PhD, Sarah Pedretti, PhD, Jonny Peter, PhD

electronic resource

View item; View item

Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD: a case control study

Mae, Haruki, Fujimaru, Takuya^{Aff1, IDs41100024005413_cor2}, Shimoyama, Koutarou, Kadota, Nozomi, Konishi, Kasumi, Itou, Yugo, Nagahama, Masahiko, Taki, Fumika, Nakayama, Masaaki

Sacubitril/Valsartan vs ACE Inhibitors or ARBs

Endurance Evbayekha, MD, Abiodun Benjamin Idowu, MD, Shane LaRue, MD

electronic resource

View item; View item

Retrospective evaluation of risk factors for worsening renal function after angiotensin‐converting enzyme inhibitor treatment in dogs

Yelim Lee, Minju Baek, Dongseop Lee, Jinyeong Park, Yeon Chae, Byeong‐Teck Kang, Taesik Yun, Hakhyun Kim

electronic resource

View item; View item

Dose‐exposure‐response of CARDALIS® (benazepril/spironolactone) on the classical and alternative arms of the renin‐angiotensin‐aldosterone system in healthy dogs

Elizabeth Manson, Jessica L. Ward, Maria Merodio, Emilie Guillot, Thomas Blondel, Karin Allenspach, Oliver Domenig, Jonathan P. Mochel

electronic resource

View item; View item

Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine

Dragoi, Cristina Manuela, Nicolae, Alina Crenguța, Dumitrescu, Ion-Bogdan

application/octet-stream

Alterations in platelet activity and endothelial glycocalyx biomarkers by treatment with an angiotensin converting enzyme inhibitor or an alpha-1 adrenoceptor antagonist in patients with hypertension: results from the DoRa study

Mikael Ekholm, Andreas Jekell, Kristina Lundwall, Joakim Alfredsson, Tomas L Lindahl, Håkan Wallén, Thomas Kahan

electronic resource

View item; View item

Safety of ACEI/ARB use in the early

Dahai Fu, Jin Li, Guanglan Zeng, Maozhi Tang

electronic resource

View item; View item

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study

Seok Hui Kang, Gui Ok Kim, Bo Yeon Kim, Eun Jung Son, Jun Young Do

electronic resource

View item; View item

Current Approaches to Treatment and Protein Intake Management in Pre-Dialysis Chronic Kidney Disease: Impact on Physical Exercise

Olga Beata Wieczorek, Daria Aleksandrowicz, Marta Głąbień, Zofia Jakubczak, Paweł Miłkowski, Maria Weronika Zimniak, Aneta Kondratowicz, Patryk Śliwiak, Karolina Kusiak, Anna Kuśnierz

electronic resource

View item; View item